The cost of new cures – inside the NCE market
Reducing the attrition rate of new chemical entities (NCEs) in the drug development pipeline is an important issue.…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Apr 16
Reducing the attrition rate of new chemical entities (NCEs) in the drug development pipeline is an important issue.…
29 Sep 15
Peptide and protein drugs are becoming more popular but face significant hurdles in development. Natalie Healey meets Dr…
28 Sep 15
As pharma deals with patent cliffs, reduced healthcare spending and increasingly stringent regulations, drug development has become more…
31 Mar 15
As the pharmaceutical industry shifts to make way for more complex products and patients with a wide range…
31 Mar 15
Peptide drugs are on the up, but most have to be injected, which is hindering mass uptake. Joël…
30 Sep 14
As the market for prefilled syringes grows, an increasing number of drugs are being administered in this way.…
04 Jul 14
Single-dose disposable inhalers represent the cutting edge of inhalation drug delivery – indicated for emergency therapies and vaccines…
30 May 14
Nexavar, the drug developed by Bayer and Amgen unit Onyx Pharmaceuticals to treat advanced kidney and liver cancers,…
14 Apr 14
Lipid-based drug delivery systems may be promising options for improving the oral bioavailability of new compounds, but the…
24 Feb 14
Pfizer Inc has announced that the 'Community-Acquired Pneumonia Immunisation Trial in Adults' (CAPiTA) − the landmark study of…